Oakworth Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $59.9K | Hold |
663
| – | – | ﹤0.01% | 423 |
|
|
2025
Q4 | $59.6K | Sell |
663
-16
| -2% | -$1.52K | ﹤0.01% | 412 |
|
|
2025
Q3 | $66.9K | Buy |
679
+439
| +183% | +$43.5K | ﹤0.01% | 406 |
|
|
2025
Q2 | $21.9K | Buy |
240
+40
| +20% | +$3.87K | ﹤0.01% | 436 |
|
|
2025
Q1 | $22.6K | Hold |
200
| – | – | ﹤0.01% | 443 |
|
|
2024
Q4 | $21.1K | Sell |
200
-178
| -47% | -$19.1K | ﹤0.01% | 454 |
|
|
2024
Q3 | $40.8K | Hold |
378
| – | – | ﹤0.01% | 378 |
|
|
2024
Q2 | $41K | Buy |
378
+78
| +26% | +$9.2K | ﹤0.01% | 362 |
|
|
2024
Q1 | $39.6K | Hold |
300
| – | – | ﹤0.01% | 342 |
|
|
2023
Q4 | $36.5K | Sell |
300
-9
| -3% | -$1K | ﹤0.01% | 356 |
|
|
2023
Q3 | $34.7K | Sell |
309
-8
| -3% | -$1.02K | ﹤0.01% | 339 |
|
|
2023
Q2 | $46.2K | Sell |
317
-1
| -0.3% | -$136 | ﹤0.01% | 315 |
|
|
2023
Q1 | $41.1K | Hold |
318
| – | – | ﹤0.01% | 318 |
|
|
2022
Q4 | $40.5K | Buy |
318
+68
| +27% | +$7.89K | ﹤0.01% | 303 |
|
|
2022
Q3 | $26K | Hold |
250
| – | – | ﹤0.01% | 364 |
|
|
2022
Q2 | $26K | Hold |
250
| – | – | ﹤0.01% | 364 |
|
|
2022
Q1 | $32K | Sell |
250
-8
| -3% | -$964 | ﹤0.01% | 346 |
|
|
2021
Q4 | $32K | Sell |
258
-51
| -17% | -$6.67K | ﹤0.01% | 374 |
|
|
2021
Q3 | $44K | Sell |
309
-82
| -21% | -$12.1K | ﹤0.01% | 327 |
|
|
2021
Q2 | $61K | Sell |
391
-30
| -7% | -$4.86K | 0.01% | 292 |
|
|
2021
Q1 | $65K | Buy |
421
+22
| +6% | +$3.41K | 0.01% | 284 |
|
|
2020
Q4 | $60K | Hold |
399
| – | – | 0.01% | 264 |
|
|
2020
Q3 | $53K | Hold |
399
| – | – | 0.01% | 264 |
|
|
2020
Q2 | $46K | Hold |
399
| – | – | 0.01% | 282 |
|
|
2020
Q1 | $39K | Hold |
399
| – | – | 0.01% | 269 |
|
|
2019
Q4 | $58K | Hold |
399
| – | – | 0.01% | 276 |
|
|
2019
Q3 | $53K | Sell |
399
-292
| -42% | -$37.7K | 0.01% | 282 |
|
|
2019
Q2 | $79K | Buy |
691
+272
| +65% | +$31.9K | 0.02% | 266 |
|
|
2019
Q1 | $52K | Hold |
419
| – | – | 0.01% | 301 |
|
|
2018
Q4 | $42K | Hold |
419
| – | – | 0.01% | 310 |
|
|
2018
Q3 | $54K | Hold |
419
| – | – | 0.01% | 289 |
|
|
2018
Q2 | $45K | Hold |
419
| – | – | 0.01% | 314 |
|
|
2018
Q1 | $47K | Hold |
419
| – | – | 0.01% | 290 |
|
|
2017
Q4 | $48K | Hold |
419
| – | – | 0.01% | 295 |
|
|
2017
Q3 | $47K | Hold |
419
| – | – | 0.01% | 302 |
|
|
2017
Q2 | $52K | Hold |
419
| – | – | 0.01% | 284 |
|
|
2017
Q1 | $50K | Hold |
419
| – | – | 0.01% | 278 |
|
|
2016
Q4 | $41K | Buy |
419
+103
| +33% | +$11K | 0.01% | 286 |
|
|
2016
Q3 | $40K | Hold |
316
| – | – | 0.01% | 281 |
|
|
2016
Q2 | $37K | Hold |
316
| – | – | 0.01% | 285 |
|
|
2016
Q1 | $33K | Hold |
316
| – | – | 0.01% | 251 |
|
|
2015
Q4 | $31K | Buy |
316
+309
| +4,414% | +$30.2K | 0.01% | 237 |
|
|
2015
Q3 | $1K | Hold |
7
| – | – | ﹤0.01% | 450 |
|
|
2015
Q2 | $1K | Hold |
7
| – | – | ﹤0.01% | 456 |
|
|
2015
Q1 | $1K | Hold |
7
| – | – | ﹤0.01% | 467 |
|
|
2014
Q4 | $1K | Buy |
+7
| New | +$738 | ﹤0.01% | 457 |
|
Other funds holding ZBH
VCM
VPM
Oakworth Capital's ZBH Position: Q1 2026 in Review
Oakworth Capital held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 663 shares worth $59.9K. The position accounts for ﹤0.01% of the portfolio, ranked #423.
Oakworth Capital first reported a position in ZBH in Q4 2014 and has held it in 46 quarters since. The position peaked at $79K in Q2 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Oakworth Capital held 663 shares of Zimmer Biomet worth $59.9K as of Q1 2026.
- Oakworth Capital left its Zimmer Biomet share count unchanged in Q1 2026.
- Zimmer Biomet made up ﹤0.01% of Oakworth Capital's portfolio in Q1 2026, its #423 holding.
- Oakworth Capital first reported a position in Zimmer Biomet in Q4 2014 and has held it in 46 quarters since.
- Oakworth Capital's Zimmer Biomet position peaked at $79K in Q2 2019.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Oakworth Capital's 13F filing for Q1 2026, filed 24 Apr 2026.